221 related articles for article (PubMed ID: 25961170)
1. A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway.
Tsuneki M; Hardee S; Michaud M; Morotti R; Lavik E; Madri JA
Lab Invest; 2015 Jul; 95(7):765-80. PubMed ID: 25961170
[TBL] [Abstract][Full Text] [Related]
2. Adhesion molecule-mediated hippo pathway modulates hemangioendothelioma cell behavior.
Tsuneki M; Madri JA
Mol Cell Biol; 2014 Dec; 34(24):4485-99. PubMed ID: 25266662
[TBL] [Abstract][Full Text] [Related]
3. [Expression of bcl-2 and survivin gene products in different stages of vessel differentiation in hemangiomas].
Tan HS; Qin XJ; Wang XK
Shanghai Kou Qiang Yi Xue; 2008 Apr; 17(2):204-7. PubMed ID: 18470430
[TBL] [Abstract][Full Text] [Related]
4. Survivin: A novel marker and potential therapeutic target for human angiosarcoma.
Tsuneki M; Kinjo T; Mori T; Yoshida A; Kuyama K; Ohira A; Miyagi T; Takahashi K; Kawai A; Chuman H; Yamazaki N; Masuzawa M; Arakawa H
Cancer Sci; 2017 Nov; 108(11):2295-2305. PubMed ID: 28845553
[TBL] [Abstract][Full Text] [Related]
5. Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence.
Nguyen VA; Kutzner H; Fürhapter C; Tzankov A; Sepp N
Mod Pathol; 2006 Feb; 19(2):291-8. PubMed ID: 16424896
[TBL] [Abstract][Full Text] [Related]
6. AJUBA LIM Proteins Limit Hippo Activity in Proliferating Cells by Sequestering the Hippo Core Kinase Complex in the Cytosol.
Jagannathan R; Schimizzi GV; Zhang K; Loza AJ; Yabuta N; Nojima H; Longmore GD
Mol Cell Biol; 2016 Oct; 36(20):2526-42. PubMed ID: 27457617
[TBL] [Abstract][Full Text] [Related]
7. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis.
Chang J; Most D; Bresnick S; Mehrara B; Steinbrech DS; Reinisch J; Longaker MT; Turk AE
Plast Reconstr Surg; 1999 Jan; 103(1):1-9; discussion 10. PubMed ID: 9915157
[TBL] [Abstract][Full Text] [Related]
8. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.
Tanaka I; Osada H; Fujii M; Fukatsu A; Hida T; Horio Y; Kondo Y; Sato A; Hasegawa Y; Tsujimura T; Sekido Y
Oncogene; 2015 Jan; 34(1):73-83. PubMed ID: 24336325
[TBL] [Abstract][Full Text] [Related]
9. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Sox10, HIF-1α, Survivin, and YAP by Minocycline in the Treatment of Neurodevelopmental Handicaps following Hypoxic Insult.
Li Q; Tsuneki M; Krauthammer M; Couture R; Schwartz M; Madri JA
Am J Pathol; 2015 Sep; 185(9):2364-78. PubMed ID: 26209807
[TBL] [Abstract][Full Text] [Related]
11. KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells.
Wang L; Zou Y; Huang Z; Wang W; Li J; Bi J; Huo R
Cancer Sci; 2023 Apr; 114(4):1569-1581. PubMed ID: 36572002
[TBL] [Abstract][Full Text] [Related]
12. The flavonoid luteolin suppresses infantile hemangioma by targeting FZD6 in the Wnt pathway.
Dai Y; Zheng H; Liu Z; Wang Y; Hu W
Invest New Drugs; 2021 Jun; 39(3):775-784. PubMed ID: 33411210
[TBL] [Abstract][Full Text] [Related]
13. YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin.
Zhang W; Gao Y; Li F; Tong X; Ren Y; Han X; Yao S; Long F; Yang Z; Fan H; Zhang L; Ji H
Cancer Res; 2015 Nov; 75(21):4450-7. PubMed ID: 26363011
[TBL] [Abstract][Full Text] [Related]
14. CD44 regulation of endothelial cell proliferation and apoptosis via modulation of CD31 and VE-cadherin expression.
Tsuneki M; Madri JA
J Biol Chem; 2014 Feb; 289(9):5357-70. PubMed ID: 24425872
[TBL] [Abstract][Full Text] [Related]
15. Hippo signaling pathway is altered in Duchenne muscular dystrophy.
Vita GL; Polito F; Oteri R; Arrigo R; Ciranni AM; Musumeci O; Messina S; Rodolico C; Di Giorgio RM; Vita G; Aguennouz M
PLoS One; 2018; 13(10):e0205514. PubMed ID: 30304034
[TBL] [Abstract][Full Text] [Related]
16. [The expression of CEACAM-1 and CXCL-14 in infantile hemangioma].
Xu GQ; Lü RR; Huo R; Guo X
Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 May; 26(3):195-8. PubMed ID: 20737948
[TBL] [Abstract][Full Text] [Related]
17. Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth.
Przewratil P; Sitkiewicz A; Andrzejewska E
Cytokine; 2010 Feb; 49(2):141-7. PubMed ID: 20015661
[TBL] [Abstract][Full Text] [Related]
18. Infantile hemangiomas are arrested in an early developmental vascular differentiation state.
Dadras SS; North PE; Bertoncini J; Mihm MC; Detmar M
Mod Pathol; 2004 Sep; 17(9):1068-79. PubMed ID: 15143338
[TBL] [Abstract][Full Text] [Related]
19. Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
Li H; Fu L; Liu B; Lin X; Dong Q; Wang E
Gene; 2019 Apr; 693():16-24. PubMed ID: 30690182
[TBL] [Abstract][Full Text] [Related]
20. Cellular and extracellular markers of hemangioma.
Tan ST; Velickovic M; Ruger BM; Davis PF
Plast Reconstr Surg; 2000 Sep; 106(3):529-38. PubMed ID: 10987458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]